-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DirLhxTHNT5SDtDAsB9thZAuLf26hzi4J8uu4E1mYL+AlXIc3aZ5+wpBu+5btLgB p8Ev0I1km7XSaG17LokGUQ== 0001209191-08-068016.txt : 20081231 0001209191-08-068016.hdr.sgml : 20081231 20081231203222 ACCESSION NUMBER: 0001209191-08-068016 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081229 FILED AS OF DATE: 20081231 DATE AS OF CHANGE: 20081231 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Buzinkai Donald CENTRAL INDEX KEY: 0001409013 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08593 FILM NUMBER: 081279676 BUSINESS ADDRESS: BUSINESS PHONE: 908-566-3800 MAIL ADDRESS: STREET 1: 440 ROUTE 22 EAST CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALPHARMA INC CENTRAL INDEX KEY: 0000730469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222095212 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 440 ROUTE 22 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 BUSINESS PHONE: 866-322-2525 MAIL ADDRESS: STREET 1: 440 ROUTE 22 CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: A L PHARMA DATE OF NAME CHANGE: 19960513 FORMER COMPANY: FORMER CONFORMED NAME: A L LABORATORIES INC DATE OF NAME CHANGE: 19920703 4 1 c78984_4x0.xml MAIN DOCUMENT DESCRIPTION X0303 4 2008-12-29 1 0000730469 ALPHARMA INC ALO 0001409013 Buzinkai Donald C/O ALPHARMA INC. 440 ROUTE 22 EAST BRIDGEWATER NJ 08807 0 1 0 0 See Remarks Class A Common Stock 2008-12-29 4 D 0 401 D 0 D Class A Common Stock 2008-12-29 4 D 0 92.52 D 0 D Stock Option (right to buy) 21.47 2008-12-29 4 D 0 5000 37.00 D 2017-09-17 Class A Common Stock 5000 0 D Stock Option (right to buy) 24.05 2008-12-29 4 D 0 12370 37.00 D 2018-02-21 Class A Common Stock 12370 0 D Restricted Stock 37.00 2008-12-29 4 D 0 8621 37.00 D Class A Common Stock 8621 0 D Tendered to Albert Acquisition Corp ("Purchaser") pursuant to Purchaser's offer to purchase all of the issued and outstanding shares of Class A Common Stock at a purchase price of $37.00 per share, net to the seller in cash, without interest and subject to any required withholding of taxes, subject to the terms described in the Tender Offer Statement on Schedule TO filed by Purchaser with the SEC on September 12, 2008, as amended. Canceled pursuant to the Agreement and Plan of Merger, dated November 23, 2008, among Alpharma Inc., King Pharmaceuticals, Inc. and Albert Acquisition Corp. (the "Merger Agreement"), in exchange for the right to receive cash payment of $37.00 per share, without interest and subject to any required withholding of taxes, at the effective time of the merger. The options, which provided for vesting at a rate of 25% on each of the four anniversary dates immediately following the date of grant, subject to the forfeiture and acceleration provisions in the award agreement, whether or not vested, were fully vested and canceled pursuant to the Merger Agreement in exchange for the right to receive cash payment for each such option of the excess of $37.00 per option, without interest and subject to any required withholding of taxes, over the per-share exercise price of such option, at the effective time of the merger. The restricted stock, which provided for vesting on the third anniversary date of the grant date, subject to the forfeiture and acceleration provisions in the award agreement, whether or not vested, were fully vested and canceled pursuant to the Merger Agreement in exchange for the right to receive cash payment for each restricted stock of $37.00, without interest and subject to any required withholding of taxes, at the effective time of the merger. Vice President, Controller and Principal Accounting Officer /s/ Karen M. Sheehan, signing pursuant to Power of Attorney granted by Donald I. Buzinkai 2008-12-31 -----END PRIVACY-ENHANCED MESSAGE-----